Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04BVN
|
|||
| Former ID |
DIB007816
|
|||
| Drug Name |
PDGF-BB
|
|||
| Synonyms |
PDGF-BB (BioChaperone technology, diabetic foot ulcer/venous ulcers/burns)
Click to Show/Hide
|
|||
| Indication | Diabetic foot ulcer [ICD-11: BD54; ICD-9: 707] | Phase 3 | [1], [2] | |
| Company |
Adocia SAS
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5039). | |||
| REF 2 | ClinicalTrials.gov (NCT02236793) A Phase 3 Clinical Trial to Assess the Effectiveness of BioChaperone PDGF-BB In the Treatment of Chronic Diabetic Foot Ulcer. U.S. National Institutes of Health. | |||
| REF 3 | Clinical pipeline report, company report or official report of Adocia. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.